Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis.

Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis.
复制标题

DOI:
10.1371/journal.pone.0241265
复制
发表时间:
2020
期刊:
影响因子:
3.7
通讯作者:
Pirbonyeh N
Pirbonyeh N
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Javanmardi F;Keshavarzi A;Akbari A;Emami A;Pirbonyeh N

文献摘要

参考文献

被引文献

相似文献

基础疾病在人群罹患COVID-19时发病率和死亡率较高的脆弱性中发挥着关键作用。目前研究的目的是评估COVID-19死亡患者中基础疾病的患病率。本研究是按照PRISMA指南进行的。检索截至6月1日的PubMed、Scopus、Web of Science、Cochrane、b谷歌scholar等国际数据库的相关研究。所有报道COVID-19死亡病例中潜在疾病的相关文章均被纳入分析。在筛选和排除重复和不相关的研究后,32篇文章纳入分析。最常见的合并症是高血压、糖尿病、心血管疾病、肝病、肺病、恶性肿瘤、脑血管疾病、慢性阻塞性肺病和哮喘。在所有报告的基础疾病中,高血压和哮喘的患病率最高和最低,估计分别为46%(37% - 55%)和3%(2%- 6%)。综上所述,基础疾病在COVID-19病例预后不良、病情严重和高死亡率中起着关键作用。患有高血压、心血管疾病和糖尿病的患者应仔细监测并了解健康方案。
Underlying disease have a critical role in vulnerability of populations for a greater morbidity and mortality when they suffer from COVID-19. The aim of current study is evaluating the prevalence of underlying disease in died people with COVID-19. The current study have been conducted according to PRISMA guideline. International database including PubMed, Scopus, Web of Science, Cochrane and google scholar were searched for relevant studies up to 1 June. All relevant articles that reported underlying disease in died cases of COVID-19 were included in the analysis. After screening and excluding duplicated and irrelevant studies, 32 articles included in the analysis. The most prevalent comorbidities were hypertension, diabetes, cardiovascular disease, liver disease, lung disease, malignancy, cerebrovascular disease, COPD and asthma. Among all reported underlying disease, highest and lowest prevalence was related to hypertension and asthma which were estimated 46% (37% - 55%) and 3% (2%- 6%), respectively. In summary, underlying disease have a critical role in poor outcomes, severity of disease and high mortality rate of COVID-19 cases. Patients with hypertension, cardiovascular disease and diabetes should be carefully monitored and be aware of health protocols.
DOI: 10.1017/dmp.2020.139
发表时间: 2020-12-01
影响因子: 2.7
作者:
Chen, Yiguang;Li, Tianhua;Pan, Jun
通讯作者: Pan, Jun
DOI: 10.7189/jogh.10.011004
发表时间: 2020-06-01
影响因子: 7.2
作者:
Chen, Yifei;Zhao, Meizhen;Zang, Shuang
通讯作者: Zang, Shuang
DOI: 10.1183/13993003.00547-2020
发表时间: 2020-05-01
影响因子: 24.3
作者:
Guan, Wei-jie;Liang, Wen-hua;He, Jian-xing
通讯作者: He, Jian-xing
DOI: 10.1164/rccm.202003-0543oc
发表时间: 2020-06-01
影响因子: 24.7
作者:
Du, Yingzhen;Tu, Lei;Xu, Guogang
通讯作者: Xu, Guogang
DOI: 10.15585/mmwr.mm6913e2
发表时间: 2020-04-03
影响因子: 33.9
作者:
Chow, Nancy;Fleming-Dutra, Katherine;Ussery, Emily
通讯作者: Ussery, Emily